APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non Corticosteroid Anti-inflammatory Eyedrops

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non Corticosteroid Anti-inflammatory Eyedrops Industry Growth and Trends Forecast to 2032

Report ID 174017540119 December 2025115 pages

Choose your research edition.

Industry ResearchNon Corticosteroid Anti-inflammatory Eyedrops Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Corticosteroid Anti-inflammatory Eyedrops Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non Corticosteroid Anti-inflammatory Eyedrops market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non Corticosteroid Anti-inflammatory Eyedrops include Novartis AG, Allergan, Inc., Walgreens, Viva Opti-Free, Visine, Systane, Staples, Similasan Corporation and Rite Aid, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non Corticosteroid Anti-inflammatory Eyedrops market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non Corticosteroid Anti-inflammatory Eyedrops market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non Corticosteroid Anti-inflammatory Eyedrops market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non Corticosteroid Anti-inflammatory Eyedrops.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non Corticosteroid Anti-inflammatory Eyedrops market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non Corticosteroid Anti-inflammatory Eyedrops Market by Company

Novartis AG

Allergan, Inc.

Walgreens

Viva Opti-Free

Visine

Systane

Staples

Similasan Corporation

Rite Aid

Meda Pharmaceuticals Inc

Clear eyes

Cigna

Bausch & Lomb Inc

Bausch & Lomb

Alcon

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Type

Diclofenac

Mugabe

Ocufen

Others

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Application

Adult

Children

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Corticosteroid Anti-inflammatory Eyedrops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Corticosteroid Anti-inflammatory Eyedrops and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Corticosteroid Anti-inflammatory Eyedrops.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non Corticosteroid Anti-inflammatory Eyedrops manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non Corticosteroid Anti-inflammatory Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diclofenac Table 2. Major Company of Mugabe Table 3. Major Company of Ocufen Table 4. Major Company of Others Table 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (W Units) Table 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Type (2021-2026) Table 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 9. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Type (2021-2026) Table 10. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2021-2026) & (US$/Unit) Table 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2027-2032) & (W Units) Table 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Type (2027-2032) Table 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2027-2032) & (US$ Million) Table 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Type (2027-2032) Table 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Type (2027-2032) & (US$/Unit) Table 16. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (W Units) Table 17. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (W Units) Table 19. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (W Units) Table 23. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Type (2021-2026) & (US$ Million) Table 26. Non Corticosteroid Anti-inflammatory Eyedrops Industry Trends Table 27. Non Corticosteroid Anti-inflammatory Eyedrops Industry Drivers Table 28. Non Corticosteroid Anti-inflammatory Eyedrops Industry Opportunities and Challenges Table 29. Non Corticosteroid Anti-inflammatory Eyedrops Industry Restraints Table 30. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Market Share by Company (2021-2026) Table 32. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Company (2021-2026) & (W Units) Table 33. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Company (2021-2026) Table 34. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Non Corticosteroid Anti-inflammatory Eyedrops Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Non Corticosteroid Anti-inflammatory Eyedrops Major Company Production Sites and Headquarters Table 37. Global Non Corticosteroid Anti-inflammatory Eyedrops Company, Product Type & Application Table 38. Global Non Corticosteroid Anti-inflammatory Eyedrops Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Non Corticosteroid Anti-inflammatory Eyedrops by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2021-2026) & (W Units) Table 43. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Region (2021-2026) Table 44. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2021-2026) & (US$ Million) Table 45. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Region (2021-2026) Table 46. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2027-2032) & (W Units) Table 48. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Region (2027-2032) Table 49. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2027-2032) & (US$ Million) Table 50. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Region (2027-2032) Table 51. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (W Units) Table 54. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Application (2021-2026) Table 55. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 56. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Application (2021-2026) Table 57. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2021-2026) & (US$/Unit) Table 58. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2027-2032) & (W Units) Table 59. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Application (2027-2032) Table 60. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2027-2032) & (US$ Million) Table 61. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Application (2027-2032) Table 62. Global Non Corticosteroid Anti-inflammatory Eyedrops Price by Application (2027-2032) & (US$/Unit) Table 63. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (W Units) Table 64. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (W Units) Table 66. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (W Units) Table 70. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 77. Novartis AG Recent Development Table 78. Allergan, Inc. Company Information Table 79. Allergan, Inc. Business Overview Table 80. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 82. Allergan, Inc. Recent Development Table 83. Walgreens Company Information Table 84. Walgreens Business Overview Table 85. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 87. Walgreens Recent Development Table 88. Viva Opti-Free Company Information Table 89. Viva Opti-Free Business Overview Table 90. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 92. Viva Opti-Free Recent Development Table 93. Visine Company Information Table 94. Visine Business Overview Table 95. Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 97. Visine Recent Development Table 98. Systane Company Information Table 99. Systane Business Overview Table 100. Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 102. Systane Recent Development Table 103. Staples Company Information Table 104. Staples Business Overview Table 105. Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 107. Staples Recent Development Table 108. Similasan Corporation Company Information Table 109. Similasan Corporation Business Overview Table 110. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 112. Similasan Corporation Recent Development Table 113. Rite Aid Company Information Table 114. Rite Aid Business Overview Table 115. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 117. Rite Aid Recent Development Table 118. Meda Pharmaceuticals Inc Company Information Table 119. Meda Pharmaceuticals Inc Business Overview Table 120. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 122. Meda Pharmaceuticals Inc Recent Development Table 123. Clear eyes Company Information Table 124. Clear eyes Business Overview Table 125. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 127. Clear eyes Recent Development Table 128. Cigna Company Information Table 129. Cigna Business Overview Table 130. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 132. Cigna Recent Development Table 133. Bausch & Lomb Inc Company Information Table 134. Bausch & Lomb Inc Business Overview Table 135. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 137. Bausch & Lomb Inc Recent Development Table 138. Bausch & Lomb Company Information Table 139. Bausch & Lomb Business Overview Table 140. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 142. Bausch & Lomb Recent Development Table 143. Alcon Company Information Table 144. Alcon Business Overview Table 145. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 147. Alcon Recent Development Table 148. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 149. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 150. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2026) Table 151. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 152. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 153. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country (2021-2026) Table 156. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Share Forecast by Country (2027-2032) Table 158. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 159. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 160. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2026) Table 161. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 162. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 163. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country (2021-2026) Table 166. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 170. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2026) Table 171. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 172. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country (2021-2026) Table 176. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Share Forecast by Country (2027-2032) Table 178. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 179. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 180. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2026) Table 181. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 182. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 183. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country (2021-2026) Table 186. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 190. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2026) Table 191. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032) & (W Units) Table 192. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country (2021-2026) Table 196. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Share Forecast by Country (2027-2032) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Non Corticosteroid Anti-inflammatory Eyedrops Distributors List Table 201. Non Corticosteroid Anti-inflammatory Eyedrops Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Non Corticosteroid Anti-inflammatory Eyedrops Image Figure 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size (2021-2032) & (US$ Million) Figure 4. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (2021-2032) & (W Units) Figure 5. Diclofenac Image Figure 6. Global Diclofenac Sales YoY Growth (2021-2032) & (W Units) Figure 7. Mugabe Image Figure 8. Global Mugabe Sales YoY Growth (2021-2032) & (W Units) Figure 9. Ocufen Image Figure 10. Global Ocufen Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Type 2025 VS 2032 Figure 15. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Type in 2025 Figure 16. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Type in 2025 Figure 17. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Type in 2025 Figure 18. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Type in 2025 Figure 21. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Non Corticosteroid Anti-inflammatory Eyedrops Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adult Image Figure 28. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 29. Children Image Figure 30. Global Children Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Application 2025 VS 2032 Figure 33. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Application in 2025 Figure 34. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Application in 2025 Figure 35. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Application in 2025 Figure 36. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Application in 2025 Figure 39. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share in Value by Application in 2025 Figure 43. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Non Corticosteroid Anti-inflammatory Eyedrops Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Non Corticosteroid Anti-inflammatory Eyedrops Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Diclofenac
  • Mugabe
  • Ocufen
  • Others
Applications
  • Adult
  • Children
Companies covered
  • Novartis AG
  • Allergan, Inc.
  • Walgreens
  • Viva Opti-Free
  • Visine
  • Systane
  • Staples
  • Similasan Corporation
  • Rite Aid
  • Meda Pharmaceuticals Inc
  • Clear eyes
  • Cigna
  • Bausch & Lomb Inc
  • Bausch & Lomb
  • Alcon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non Corticosteroid Anti-inflammatory Eyedrops Market by Type
  6. 1.3.1 Diclofenac
  7. 1.3.2 Mugabe
  8. 1.3.3 Ocufen
  9. 1.3.4 Others
  10. 1.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Type
  11. 1.4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non Corticosteroid Anti-inflammatory Eyedrops Industry Trends
  2. 2.2 Non Corticosteroid Anti-inflammatory Eyedrops Industry Drivers
  3. 2.3 Non Corticosteroid Anti-inflammatory Eyedrops Industry Opportunities and Challenges
  4. 2.4 Non Corticosteroid Anti-inflammatory Eyedrops Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non Corticosteroid Anti-inflammatory Eyedrops Revenue (2021-2026)
  2. 3.2 Global Top Players by Non Corticosteroid Anti-inflammatory Eyedrops Sales (2021-2026)
  3. 3.3 Global Top Players by Non Corticosteroid Anti-inflammatory Eyedrops Price (2021-2026)
  4. 3.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non Corticosteroid Anti-inflammatory Eyedrops Major Company Production Sites & Headquarters
  6. 3.6 Global Non Corticosteroid Anti-inflammatory Eyedrops Company, Product Type & Application
  7. 3.7 Global Non Corticosteroid Anti-inflammatory Eyedrops Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non Corticosteroid Anti-inflammatory Eyedrops Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non Corticosteroid Anti-inflammatory Eyedrops Tier 1, Tier 2, and Tier 3
4 Non Corticosteroid Anti-inflammatory Eyedrops Regional Status and Outlook
  1. 4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Historic Market Size by Region
  3. 4.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Forecasted Market Size by Region
  7. 4.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non Corticosteroid Anti-inflammatory Eyedrops by Application
  1. 5.1 Non Corticosteroid Anti-inflammatory Eyedrops Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Application
  5. 5.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Allergan, Inc.
  8. 6.2.1 Allergan, Inc. Company Information
  9. 6.2.2 Allergan, Inc. Business Overview
  10. 6.2.3 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  12. 6.2.5 Allergan, Inc. Recent Developments
  13. 6.3 Walgreens
  14. 6.3.1 Walgreens Company Information
  15. 6.3.2 Walgreens Business Overview
  16. 6.3.3 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  18. 6.3.5 Walgreens Recent Developments
  19. 6.4 Viva Opti-Free
  20. 6.4.1 Viva Opti-Free Company Information
  21. 6.4.2 Viva Opti-Free Business Overview
  22. 6.4.3 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  24. 6.4.5 Viva Opti-Free Recent Developments
  25. 6.5 Visine
  26. 6.5.1 Visine Company Information
  27. 6.5.2 Visine Business Overview
  28. 6.5.3 Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  30. 6.5.5 Visine Recent Developments
  31. 6.6 Systane
  32. 6.6.1 Systane Company Information
  33. 6.6.2 Systane Business Overview
  34. 6.6.3 Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  36. 6.6.5 Systane Recent Developments
  37. 6.7 Staples
  38. 6.7.1 Staples Company Information
  39. 6.7.2 Staples Business Overview
  40. 6.7.3 Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  42. 6.7.5 Staples Recent Developments
  43. 6.8 Similasan Corporation
  44. 6.8.1 Similasan Corporation Company Information
  45. 6.8.2 Similasan Corporation Business Overview
  46. 6.8.3 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  48. 6.8.5 Similasan Corporation Recent Developments
  49. 6.9 Rite Aid
  50. 6.9.1 Rite Aid Company Information
  51. 6.9.2 Rite Aid Business Overview
  52. 6.9.3 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  54. 6.9.5 Rite Aid Recent Developments
  55. 6.10 Meda Pharmaceuticals Inc
  56. 6.10.1 Meda Pharmaceuticals Inc Company Information
  57. 6.10.2 Meda Pharmaceuticals Inc Business Overview
  58. 6.10.3 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  60. 6.10.5 Meda Pharmaceuticals Inc Recent Developments
  61. 6.11 Clear eyes
  62. 6.11.1 Clear eyes Company Information
  63. 6.11.2 Clear eyes Business Overview
  64. 6.11.3 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  66. 6.11.5 Clear eyes Recent Developments
  67. 6.12 Cigna
  68. 6.12.1 Cigna Company Information
  69. 6.12.2 Cigna Business Overview
  70. 6.12.3 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  72. 6.12.5 Cigna Recent Developments
  73. 6.13 Bausch & Lomb Inc
  74. 6.13.1 Bausch & Lomb Inc Company Information
  75. 6.13.2 Bausch & Lomb Inc Business Overview
  76. 6.13.3 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  78. 6.13.5 Bausch & Lomb Inc Recent Developments
  79. 6.14 Bausch & Lomb
  80. 6.14.1 Bausch & Lomb Company Information
  81. 6.14.2 Bausch & Lomb Business Overview
  82. 6.14.3 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  84. 6.14.5 Bausch & Lomb Recent Developments
  85. 6.15 Alcon
  86. 6.15.1 Alcon Company Information
  87. 6.15.2 Alcon Business Overview
  88. 6.15.3 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  90. 6.15.5 Alcon Recent Developments
7 North America by Country
  1. 7.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country
  2. 7.1.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026)
  4. 7.1.3 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
  6. 7.2.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026)
  8. 7.2.3 North America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country
  2. 8.1.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026)
  4. 8.1.3 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
  6. 8.2.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country
  2. 9.1.1 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
  6. 9.2.1 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country
  2. 10.1.1 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026)
  4. 10.1.3 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
  6. 10.2.1 South America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026)
  8. 10.2.3 South America Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country
  2. 11.1.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country
  6. 11.2.1 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non Corticosteroid Anti-inflammatory Eyedrops Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non Corticosteroid Anti-inflammatory Eyedrops Value Chain Analysis
  2. 12.1.1 Non Corticosteroid Anti-inflammatory Eyedrops Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non Corticosteroid Anti-inflammatory Eyedrops Production Mode & Process
  7. 12.2 Non Corticosteroid Anti-inflammatory Eyedrops Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non Corticosteroid Anti-inflammatory Eyedrops Distributors
  10. 12.2.3 Non Corticosteroid Anti-inflammatory Eyedrops Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst